Feasibility Study of the Hemolung Respiratory Assist System (Germany)

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Hypercapnic Respiratory Failure, COPD, ARDS
Interventions
DEVICE

Hemolung Respiratory Assist System

Patients meeting the inclusion criteria will be placed on the Hemolung Respiratory Assist System. Patients will be weaned from non-invasive or invasive ventilation and then the Hemolung RAS. Hemolung support will be provided for up to 7 days. Follow-up exams will be performed every 15 days until hospital discharge or 30 days from completion of Hemolung therapy, whichever is later.

Trial Locations (7)

22291

Asklepios Klinik Barmbek, Hamburg

42699

Krankenhaus Bethanien, Solingen

45122

Ruhrlandklinik Das Lungenzentrum Essen-Heidhausen Abt.: Pneumologie, Essen

69126

Thoraxklinik am Universitätsklinikum Heidelberg, Heidelberg

93093

Klinik Donaustauf, Donaustauf

Unknown

Universitätsklinikum Bonn, Bonn

D-37077

Universitätsmedizin Göttingen, Göttingen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alung Technologies

INDUSTRY